199 related articles for article (PubMed ID: 18091584)
1. Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection.
Jamnicki-Abegg M; Weihrauch D; Chiari PC; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
J Cardiovasc Pharmacol; 2007 Dec; 50(6):670-6. PubMed ID: 18091584
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
[TBL] [Abstract][Full Text] [Related]
3. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats.
Araiza-Saldaña CI; Reyes-García G; Bermúdez-Ocaña DY; Pérez-Severiano F; Granados-Soto V
Eur J Pharmacol; 2005 Dec; 527(1-3):60-70. PubMed ID: 16305795
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil promotes adipogenesis through a PKG pathway.
Zhang X; Ji J; Yan G; Wu J; Sun X; Shen J; Jiang H; Wang H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1054-9. PubMed ID: 20471953
[TBL] [Abstract][Full Text] [Related]
5. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
Schäfer A; Fraccarollo D; Pförtsch S; Flierl U; Vogt C; Pfrang J; Kobsar A; Renné T; Eigenthaler M; Ertl G; Bauersachs J
Br J Pharmacol; 2008 Mar; 153(5):886-93. PubMed ID: 17891166
[TBL] [Abstract][Full Text] [Related]
6. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
7. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
8. Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection.
Wang X; Fisher PW; Xi L; Kukreja RC
J Mol Cell Cardiol; 2008 Jan; 44(1):105-13. PubMed ID: 18021798
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells.
Tantini B; Manes A; Fiumana E; Pignatti C; Guarnieri C; Zannoli R; Branzi A; Galié N
Basic Res Cardiol; 2005 Mar; 100(2):131-8. PubMed ID: 15739122
[TBL] [Abstract][Full Text] [Related]
10. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
Li B; Yang L; Shen J; Wang C; Jiang Z
Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5.
Das S; Maulik N; Das DK; Kadowitz PJ; Bivalacqua TJ
Drugs Exp Clin Res; 2002; 28(6):213-9. PubMed ID: 12776574
[TBL] [Abstract][Full Text] [Related]
12. Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass.
Szabó G; Radovits T; Veres G; Krieger N; Loganathan S; Sandner P; Karck M
Eur J Cardiothorac Surg; 2009 Oct; 36(4):657-64. PubMed ID: 19523842
[TBL] [Abstract][Full Text] [Related]
13. The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway.
Pyriochou A; Zhou Z; Koika V; Petrou C; Cordopatis P; Sessa WC; Papapetropoulos A
J Cell Physiol; 2007 Apr; 211(1):197-204. PubMed ID: 17226792
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism.
Dias-Junior CA; Montenegro MF; Florencio BC; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):374-9. PubMed ID: 18834358
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil and glyceryl trinitrate reduce tactile allodynia in streptozotocin-injected rats.
Araiza-Saldaña CI; Rocha-González HI; Ambriz-Tututi M; Castañeda-Corral G; Caram-Salas NL; Hong E; Granados-Soto V
Eur J Pharmacol; 2010 Apr; 631(1-3):17-23. PubMed ID: 20079349
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil promotes ischemia-induced angiogenesis through a PKG-dependent pathway.
Senthilkumar A; Smith RD; Khitha J; Arora N; Veerareddy S; Langston W; Chidlow JH; Barlow SC; Teng X; Patel RP; Lefer DJ; Kevil CG
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1947-54. PubMed ID: 17585066
[TBL] [Abstract][Full Text] [Related]
17. Multiple affinity states of cGMP-specific phosphodiesterase for sildenafil inhibition defined by cGMP-dependent and cGMP-independent mechanisms.
Rybalkina IG; Tang XB; Rybalkin SD
Mol Pharmacol; 2010 Apr; 77(4):670-7. PubMed ID: 20086037
[TBL] [Abstract][Full Text] [Related]
18. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits.
Bremer YA; Salloum F; Ockaili R; Chou E; Moskowitz WB; Kukreja RC
Pediatr Res; 2005 Jan; 57(1):22-7. PubMed ID: 15531735
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effects of sildenafil on post-ischaemic left ventricular function in the rat isolated heart.
Kolettis TM; Kontaras K; Spartinos I; Maniotis C; Varnavas V; Koutouzis M; Mourouzis I; Papalois A; Pantos C; Kyriakides ZS
J Pharm Pharmacol; 2010 Mar; 62(3):346-51. PubMed ID: 20487218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
